<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">HIV- </span>
   <span class="font14">HIV </span>
   <span class="font14">infection </span>
   <span class="font13">virus </span>
   <span class="font13">individuals </span>
   <span class="font13">infected </span>
   <span class="font12">viral </span>
   <span class="font12">[]. </span>
   <span class="font12">disease </span>
   <span class="font12">human </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">type </span>
   <span class="font11">West </span>
   <span class="font11">compared </span>
   <span class="font11">cure </span>
   <span class="font11">patients </span>
   <span class="font11">progression </span>
   <span class="font11">HIV-, </span>
   <span class="font11">studies </span>
   <span class="font11">T-cell </span>
   <span class="font11">cells </span>
   <span class="font11">cohort </span>
   <span class="font11">HIV--infected </span>
   <span class="font11">levels </span>
   <span class="font11">{border-style </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">AIDS </span>
   <span class="font11">cell </span>
   <span class="font11">immune </span>
   <span class="font11">lower </span>
   <span class="font11">reservoir </span>
   <span class="font10">control </span>
   <span class="font10">functional </span>
   <span class="font10">infections </span>
   <span class="font10">responses </span>
   <span class="font10">activation </span>
   <span class="font10">load </span>
   <span class="font10">plasma </span>
   <span class="font10">remission </span>
   <span class="font10">replication </span>
   <span class="font10">reported </span>
   <span class="font10">Hum </span>
   <span class="font10">capacity </span>
   <span class="font10">clinical </span>
   <span class="font10">different </span>
   <span class="font10">mortality </span>
   <span class="font10">rate </span>
   <span class="font10">HIV-/ </span>
   <span class="font10">Infect </span>
   <span class="font10">Res </span>
   <span class="font10">model </span>
   <span class="font10">neutralizing </span>
   <span class="font10">study </span>
   <span class="font10">treatment </span>
   <span class="font10">DNA </span>
   <span class="font10">Guinea-Bissau, </span>
   <span class="font10">However, </span>
   <span class="font10">Med </span>
   <span class="font10">T-cells </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">[], </span>
   <span class="font10">antibodies </span>
   <span class="font10">antibody </span>
   <span class="font10">reduced </span>
   <span class="font10">similar </span>
   <span class="font10">strategies </span>
   <span class="font10">ART </span>
   <span class="font10">Guinea-Bissau </span>
   <span class="font10">Guinea-Bissau: </span>
   <span class="font10">Moreover, </span>
   <span class="font10">SilvaTe </span>
   <span class="font10">associated </span>
   <span class="font10">der </span>
   <span class="font10">dual-infected </span>
   <span class="font10">follow-up </span>
   <span class="font10">prevalence </span>
   <span class="font10">results </span>
   <span class="font10">Africa </span>
   <span class="font10">Virol </span>
   <span class="font10">[–]. </span>
   <span class="font10">cellular </span>
   <span class="font10">differences </span>
   <span class="font10">dually </span>
   <span class="font10">high </span>
   <span class="font10">latent </span>
   <span class="font10">level </span>
   <span class="font10">mRNA </span>
   <span class="font10">natural </span>
   <span class="font10">proviral </span>
   <span class="font10">px; </span>
   <span class="font10">size </span>
   <span class="font10">trials </span>
   <span class="font10">types </span>
   <span class="font10">{font-family </span>
   <span class="font10">(HIV-) </span>
   <span class="font10">Bissau, </span>
   <span class="font10">Virol./JVI...-. </span>
   <span class="font10">data </span>
   <span class="font10">decline </span>
   <span class="font10">difference </span>
   <span class="font10">dual </span>
   <span class="font10">early </span>
   <span class="font10">elite </span>
   <span class="font10">font-size </span>
   <span class="font10">frequency </span>
   <span class="font10">infectionJ </span>
   <span class="font10">latency </span>
   <span class="font10">long-term </span>
   <span class="font10">possible </span>
   <span class="font10">showed </span>
   <span class="font10">shown </span>
   <span class="font10">stages </span>
   <span class="font10">testing </span>
   <span class="font10">therapy </span>
   <span class="font10">vitro </span>
   <span class="font10">Acquir </span>
   <span class="font10">African </span>
   <span class="font10">Bissau </span>
   <span class="font10">Defic </span>
   <span class="font10">Immune </span>
   <span class="font10">Limited </span>
   <span class="font10">Retrovir./aid.. </span>
   <span class="font10">achieve </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">controllers </span>
   <span class="font10">distinguish </span>
   <span class="font10">double; </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">loads </span>
   <span class="font10">main </span>
   <span class="font10">models </span>
   <span class="font10">molecular </span>
   <span class="font10">needed </span>
   <span class="font10">rates </span>
   <span class="font10">reactivation </span>
   <span class="font10">relapse-free </span>
   <span class="font10">research </span>
   <span class="font10">survival </span>
   <span class="font10">trial </span>
   <span class="font10">using </span>
   <span class="font10">years </span>
   <span class="font10">–]. </span>
   <span class="font10">Dis./ </span>
   <span class="font10">HIV--specific </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">Int </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Lund </span>
   <span class="font10">SilvaZJet </span>
   <span class="font10">University, </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broadly </span>
   <span class="font10">challenges </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">described </span>
   <span class="font10">despite </span>
   <span class="font10">dual-infection </span>
   <span class="font10">group </span>
   <span class="font10">higher </span>
   <span class="font10">individuals, </span>
   <span class="font10">large </span>
   <span class="font10">latently </span>
   <span class="font10">long </span>
   <span class="font10">low </span>
   <span class="font10">number </span>
   <span class="font10">order </span>
   <span class="font10">persistent </span>
   <span class="font10">potent </span>
   <span class="font10">provide </span>
   <span class="font10">rapid </span>
   <span class="font10">rebound </span>
   <span class="font10">single-infected </span>
   <span class="font10">slower </span>
   <span class="font10">solid; </span>
   <span class="font10">transcription </span>
   <span class="font10">transmission </span>
   <span class="font10">vivo </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">ART, </span>
   <span class="font10">Africa: </span>
   <span class="font10">Gag-specific </span>
   <span class="font10">HIV-- </span>
   <span class="font10">HIV-. </span>
   <span class="font10">HIV-J </span>
   <span class="font10">HIV-specific </span>
   <span class="font10">HIVee./S-()- </span>
   <span class="font10">Health </span>
   <span class="font10">Medicine, </span>
   <span class="font10">RNA </span>
   <span class="font10">SIV </span>
   <span class="font10">approximately </span>
   <span class="font10">aviraemic </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">changes </span>
   <span class="font10">correlate </span>
   <span class="font10">courier; </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">distinct </span>
   <span class="font10">does </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">envelope </span>
   <span class="font10">epidemiology </span>
   <span class="font10">established </span>
   <span class="font10">explain </span>
   <span class="font10">frequent </span>
   <span class="font10">gag </span>
   <span class="font10">groups </span>
   <span class="font10">humanized </span>
   <span class="font10">important </span>
   <span class="font10">including </span>
   <span class="font10">indicated </span>
   <span class="font10">individuals. </span>
   <span class="font10">infections, </span>
   <span class="font10">information </span>
   <span class="font10">insights </span>
   <span class="font10">killer </span>
   <span class="font10">lack </span>
   <span class="font10">lessons </span>
   <span class="font10">need </span>
   <span class="font10">novel </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">population </span>
   <span class="font10">production </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">represent </span>
   <span class="font10">seen </span>
   <span class="font10">simian </span>
   <span class="font10">subjects </span>
   <span class="font10">suggested </span>
   <span class="font10">tat </span>
   <span class="font10">tests </span>
   <span class="font10">understanding </span>
   <span class="font10">untreated </span>
   <span class="font10">viraemia </span>
  </p>
 </body>
</html>
